Help improve our website & get rewarded. Register your interest and you could win a gift card up to €50!

Abstracts

Abstracts; 

We can’t afford to turn a blind eye to myopia 

Bourke CM, Loughman J, Fltcroft DI, Loskutova E, O’Brien C. We can’t afford to turn a blind eye to myopia, QJM: An International Journal of Medicine, 2019;hcz076, 

 

Smartphone usage as a contributor to myopia 

Loughman J, McCrann S, Paudel N, Butler JS, Flitcroft DI. (2019) Smartphone Usage as a Possible Contributor to the Increasing Prevalence of Myopia. Investigative Ophthalmology & Visual Science, 60 (9), 5855-5855. 

 

Association between myopia and zinc in KNHANES 

Burke N, Flitcroft DI, Butler JS, Loughman J. (2019) Association between Myopia and Lower Serum Zinc Status in Adolescents: The 2010 Korean National Health and Nutrition Examination Study. Investigative Ophthalmology & Visual Science, 60 (9), 5826-5826. 

 

Attitudes and barriers to myopia control among optometrists 

McCrann S, Flitcroft DI, Butler JS, Barrett C, Loughman J. (2019) Attitudes, Beliefs and Perceived Barriers toward Myopia Management in clinical practice. Investigative Ophthalmology & Visual Science, 60 (9), 5821-5821 

 

Novel myopia genes identified from syndromic myopia 

Flitcroft DI, Loughman J, Wildsoet CF, Williams C, Guggenheim JA. (2017). Novel Myopia Genes and Pathways identified from Syndromic Forms of Myopia. Investigative Ophthalmology & Visual Science 58 (8), 5480-5480 

 

Big Data in epidemiological studies of refractive error 

Moore M, Loughman J, Wahl S, Ohlendorf A, Flitcroft DI. (2017). The Potential value of Big-Data for Epidemiological Studies of Refractive Error. Investigative Ophthalmology & Visual Science 58 (8), 2397-2397. 

 

Visual lifestyle of myopic children assessed with AI-powered wearable monitoring 

Michael Mrochen, Pavel Zakharov, Burcu Nurözler Tabakcι, Cafer Tanrιverdi, Aylin Kιlιç, Daniel Ian Flitcroft; Visual lifestyle of myopic children assessed with AI-powered wearable monitoring. Invest. Ophthalmol. Vis. Sci. 2020;61(7):82. 

 

Myopia Progression Centiles from Real World Data: An Ecologically Valid Tool for Myopia Treatment Efficacy Monitoring? 

James Loughman, Michael Moore, Daniel Ian Flitcroft; Myopia Progression Centiles from Real World Data: An Ecologically Valid Tool for Myopia Treatment Efficacy Monitoring?. Invest. Ophthalmol. Vis. Sci. 2020;61(7):79. 

 

Centile-based analysis of refractive development in the MiSight® 1 day Myopia Control trial. 

Daniel Ian Flitcroft, James Loughman, Baskar Arumugam, Arthur Bradley, Paul Chamberlain; Centile-based analysis of refractive development in the MiSight® 1 day Myopia Control trial. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1372. 

 

Incidence and progression of myopia in young adults. 

Michael Moore, Ian Flitcroft, Gareth Lingham, Eoin Kerin, Ernest Kyei Nkansah, Matilda Biba, James Loughman; Incidence and progression of myopia in young adults. Invest. Ophthalmol. Vis. Sci. 2024;65(7):171. 

 

Biometrically defining myopia with the Refractive Mechanism Map: Relationship with myopia progression and treatment efficacy  

Ernest Kyei Nkansah, Gareth Lingham, James Loughman, Emmanuel Kobia-Acquah, Ian Flitcroft; Biometrically defining myopia with the Refractive Mechanism Map: Relationship with myopia progression and treatment efficacy.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):142. 

 

Tolerability and Short-Term Effects of Low-Concentration Atropine Eye Drops on Ocular Outcomes in Myopic Young Adults 

Eoin Kerin, Gareth Lingham, Alicia Gomez Sanchez, James Loughman, Ian Flitcroft; Tolerability and Short-Term Effects of Low-Concentration Atropine Eye Drops on Ocular Outcomes in Myopic Young Adults. Invest. Ophthalmol. Vis. Sci. 2024;65(7):140. 

 

The MOSAIC Study: Year 3 results of 0.01% and 0.05% Atropine treatment in a European Population 

James Loughman, Gareth Lingham, Ernest Kyei Nkansah, Emmanuel Kobia-Acquah, Ian Flitcroft; The MOSAIC Study: Year 3 results of 0.01% and 0.05% Atropine treatment in a European Population. Invest. Ophthalmol. Vis. Sci. 2024;65(7):427.  

 

Choroidal thickness as a biomarker for axial length change 

Biba M, Lingham G, Kobia Acquah K, Loughman J, Flitcroft DI. Choroidal thickness as a biomarker for axial length change. Acta Ophthalmologica 102. 2024. European Vision & Eye Research Conference. https://doi.org/10.1111/aos.16119 

 

Are red/green colour vision deficient individuals at altered risk of myopia? 

 G Lingham, M Biba, S Harrington, D Mackey, J Loughman. Are red/green colour vision deficient individuals at altered risk of myopia? Acta Ophthalmologica 102. 2024. European Vision & Eye Research Conference